Accessed:
ChemSpider Search and share chemistrynav-icon

sparsentan

Molecular formula:C32H40N4O5S
Average mass:592.755
Monoisotopic mass:592.271941
ChemSpider ID:8433365
plus-iconless-iconStructural identifiers
  • Names down_Arrow
plus-iconless-iconNames and synonyms
Verified

254740-64-2

[RN]

4′-((2-butyl-4-oxo-1,3-diazaspiro(4.4)non-1-en-3-yl)methyl)-N-(4,5-dimethyl-3-isoxazolyl)-2′-(ethoxymethyl)(1,1′-biphenyl)-2-sulfonamide

4′-({2-butyl-4-oxo-1,3-diazaspiro[4.4]non-1-en-3-yl}methyl)-N-(4,5-dimethyl-1,2-oxazol-3-yl)-2′-(ethoxymethyl)-[1,1′-biphenyl]-2-sulfonamide

4′-[(2-Butyl-4-oxo-1,3-diazaspiro[4.4]non-1-en-3-yl)methyl]-N-(4,5-dimethyl-1,2-oxazol-3-yl)-2′-(ethoxymethyl)-2-biphenylsulfonamid

[German]

[ACD/IUPAC Name]

4′-[(2-Butyl-4-oxo-1,3-diazaspiro[4.4]non-1-en-3-yl)methyl]-N-(4,5-dimethyl-1,2-oxazol-3-yl)-2′-(ethoxymethyl)-2-biphenylsulfonamide

[ACD/IUPAC Name]

4′-[(2-Butyl-4-oxo-1,3-diazaspiro[4.4]non-1-én-3-yl)méthyl]-N-(4,5-diméthyl-1,2-oxazol-3-yl)-2′-(éthoxyméthyl)-2-biphénylsulfonamide

[French]

[ACD/IUPAC Name]

4′-[(2-butyl-4-oxo-1,3-diazaspiro[4.4]non-1-en-3-yl)methyl]-N-(4,5-dimethyl-1,2-oxazol-3-yl)-2′-(ethoxymethyl)biphenyl-2-sulfonamide

[1,1′-Biphenyl]-2-sulfonamide, 4′-[(2-butyl-4-oxo-1,3-diazaspiro[4.4]non-1-en-3-yl)methyl]-N-(4,5-dimethyl-3-isoxazolyl)-2′-(ethoxymethyl)-

[ACD/Index Name]

esparsentán

[Spanish]

[INN]

sparsentan

[INN] [USAN]

sparsentan

[French]

[INN]

sparsentanum

[Latin]

[INN]

Спарсентан

[Russian]

[INN]

سبارسينتان

[Arabic]

[INN]

司帕生坦

[Chinese]

[INN]
Unverified

1-(Dimethylamino)cyclopentanecarbonitrile

[ACD/IUPAC Name]

2-[4-({2-BUTYL-4-OXO-1,3-DIAZASPIRO[4.4]NON-1-EN-3-YL}METHYL)-2-(ETHOXYMETHYL)PHENYL]-N-(DIMETHYL-1,2-OXAZOL-3-YL)BENZENESULFONAMIDE

2-[4-[(2-butyl-4-keto-1,3-diazaspiro[4.4]non-1-en-3-yl)methyl]-2-(ethoxymethyl)phenyl]-N-(4,5-dimethylisoxazol-3-yl)benzenesulfonamide

2-[4-[(2-butyl-4-oxo-1,3-diazaspiro[4.4]non-1-en-3-yl)methyl]-2-(ethoxymethyl)phenyl]-N-(4,5-dimethyl-1,2-oxazol-3-yl)benzenesulfonamide

2-[4-[(2-butyl-4-oxo-1,3-diazaspiro[4.4]non-1-en-3-yl)methyl]-2-(ethoxymethyl)phenyl]-N-(4,5-dimethyl-3-isoxazolyl)benzenesulfonamide

2-[4-[(2-butyl-4-oxo-1,3-diazaspiro[4.4]non-1-en-3-yl)methyl]-2-(ethoxymethyl)phenyl]-N-(4,5-dimethylisoxazol-3-yl)benzenesulfonamide

4′-(2-Butyl-4-oxo-1,3-diaza-spiro[4.4]non-1-en-3-ylmethyl)-2′-ethoxymethyl-biphenyl-2-sulfonic acid (4,5-dimethyl-isoxazol-3-yl)-amide

4′-[(2-Butyl-4-oxo-1,3-diazaspiro[4.4]non-1-en-3-yl)methyl]-N-(4,5-dimethyl-3-isoxazolyl)-2′-(ethoxymethyl)-[1,1′-biphenyl]-2-sulfonamide

4″-(2-Butyl-4-oxo-1,3-diaza-spiro[4.4]non-1-en-3-ylmethyl)-2″-ethoxymethyl-biphenyl-2-sulfonic acid (4,5-dimethyl-isoxazol-3-yl)-amide

MFCD16628036

[MDL number]

sparsentan (re-021)

plus-iconless-iconDatabase IDs